bioRxivGenomicsPreprint
Detection of potential new SARS-CoV-2 Gamma-related lineage in Tocantins shows the spread and ongoing evolution of P.1 in Brazil
Ueric José Borges de SouzaiD, Raíssa Nunes dos SantosiD, Aline BelmokiD, Fernando Lucas de MeloiD, Jucimária Dantas GalvãoiD, Sirlene Damasceno, Tereza Cristina Vieira de Rezende, Miguel de Souza AndradeiD, Bergmann Morais RibeiroiD, José Carlos Ribeiro JúnioriD, Rodrigo Franco de CarvalhoiD, Isac Gabriel Cunha dos SantosiD, Marcio Sacramento de OliveiraiD, Fernando Rosado SpilkiiD, Fabrício Souza CamposiD
Abstract
After more than a year of the pandemic situation of COVID-19, the United Kingdom (UK), South Africa, and Brazil became the epicenter of new lineages of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Variants of Concern (VOCs) were identified through a continuous genomic surveillance global effort, the B.1.1.7 (Alpha), B.1.351 (Beta), B.1.617.2 (Delta), and P.1 (Gamma) harboring a constellation set of mutations. This research aims to: (i) report the predominance of the Gamma (P.1) lineage presenting the epidemiological situation of the SARS-CoV-2 genomic surveillance at the state of Tocantins, and (ii) describe the emergence of possible new mutations and viral variants with the potential new lineage (P1-related) represented by 8 genomes from the Tocantins harboring the mutation L106F in ORF3a. At the moment, 6,687 SARS-CoV-2 genomes from GISAID carry this mutation. The whole-genome sequencing has an important role in understanding the evolution and genomic diversity of SARS-CoV-2, thus, the continuous monitoring will help in the control measures and restrictions imposed by the secretary of health of the state to prevent the spread of variants.
- organism: human
- assay: whole-genome sequencing
- research focus: variant calling
- approach: statistical model
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Predominance of the SARS-CoV-2 lineage P.1 and its sublineage P.1.2 in patients from the metropolitan region of Porto Alegre, Southern Brazil in March 2021: a phylogenomic analysis
Vinícius Bonetti Franceschi, Gabriel Dickin Caldana, … Claudia Elizabeth Thompson·PathogensPeer-reviewed·Aug 5, 2021
- SARS-CoV-2 introduction and lineage dynamics across three epidemic peaks in Southern Brazil: massive spread of P.1
Ana Paula Muterle Varela, Janira Prichula, … Ana Beatriz Gorini da Veiga·Infection Genetics and EvolutionPeer-reviewed·Nov 17, 2021
- Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil
Carolina Moreira Voloch, Ronaldo da Silva Francisco, … Ana Tereza Ribeiro de Vasconcelos·Journal of VirologyPeer-reviewed·Mar 1, 2021
- Genomic epidemiology reveals the impact of national and international restrictions measures on the SARS-CoV-2 epidemic in Brazil
Marta Giovanetti, Svetoslav Nanev Slavov, … Maria Carolina Elias·Nature MicrobiologyPeer-reviewed·Aug 18, 2022
- High rate of mutational events in SARS-CoV-2 genomes across Brazilian geographical regions, February 2020 to June 2021
Ueric José Borges de Souza, Raíssa Nunes dos Santos, … Corona-ômica.BR/MCTI Network·VirusesPeer-reviewed·Sep 10, 2021
- A potential SARS-CoV-2 variant of interest (VOI) harboring mutation E484K in the Spike protein was identified within lineage B.1.1.33 circulating in Brazil
P. C. Resende, T. Graf, … M. M. Siqueira·bioRxiv·Mar 12, 2021